Back to Search

MICHAEL LUGGEN, MD

MD

Rheumatology Physician

NPI: 1386635431IndividualAccepts Medicare

Specialties, Licenses & Credentials

Rheumatology PhysicianPrimary

Internal Medicine — Rheumatology

Code: 207RR0500X

35040536(OH)

CMS Specialties

PrimaryRHEUMATOLOGY

Additional

INTERNAL MEDICINE

Education

COLUMBIA UNIVERSITY COLLEGE OF PHYSICIANS AND SURGEONS

Class of 1974

Research & Publications (10)

Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy.
PMID 17921185·Ann Rheum Dis·2008
4-observational
Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis.
PMID 17622600·JAMA·2007
4-observational
T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantation.
PMID 17020493·Annu Rev Med·2007
6-review
Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial.
PMID 16935912·Ann Rheum Dis·2007
3-trial
Hypertrophic pachymeningitis in rheumatoid arthritis after adalimumab administration.
PMID 16981287·J Rheumatol·2006
5-case
Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.
PMID 16162882·N Engl J Med·2005
3-trial
Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
PMID 15290730·J Rheumatol·2004
3-trial
Trials are short, disease long: measuring drug utility beyond clinical trials.
PMID 14760785·J Rheumatol·2004
6-review
Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial.
PMID 12416946·Ann Intern Med·2002
3-trial
Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion.
PMID 12115176·Arthritis Rheum·2002
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
311 STRAIGHT ST
CINCINNATI, OH 45219

Location

Practice Location

311 STRAIGHT ST, CINCINNATI, OH
(513) 559-2898

Quick Facts

NPI
1386635431
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
52
Publications
10

Are you this provider?

Claim Your Profile